|
Medical device maker Covidien PLC is facing scrutiny from the U.S. Food and Drug Administration over the way its management handled the recall of its Duet TRS surgical staples.
more
By PBN Staff
|
|
Medical technology maker Covidien Plc. reported third quarter earnings of $453 million, or 93 cents per diluted share, a drop of 15.3 percent from the $535 million, or $1.07 per diluted share reported during the same period in 2011.
more
By PBN Staff
|
|
Medical imaging innovator Lucidux LLC has landed a $250,000 investment from public venture capital firm Slater Technology Fund.
more
By Patrick Anderson |
|
Medical technology maker Covidien Ltd. has officially opened its Shanghai-based research and development facility, the China Technology Center, the company announced Thursday.
more
By Emily Greenhalgh |
|
PROVIDENCE – Performance Physical Therapy recently announced the opening of its newest of six clinics, in the Smithfield Medical Center in Smithfield. A seventh clinic is scheduled to open later this month in Barrington at 310 Maple Ave.
more
8/20/12
|
|
WOONSOCKET – MultiCell Technologies announced on Aug. 10 its updates on preclinical research results for MCT-465 and MCT-485, the first of a family of prospective cancer therapeutics based on the use of its patented signaling technology. MCT-465 and MCT-485 are being investigated as prospective treatments for primary liver cancer and triple-negative breast cancer.
more
8/20/12
|
|
EpiVax Inc., led by founder and CEO Dr. Anne S. De Groot, has been awarded an additional $300,000 Small Business Innovation Research grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases, the company announced Friday.
more
By Emily Greenhalgh |
|
Medical device maker Covidien PLC landed 501(k) clearance by the U.S. Food and Drug Administration for its reusable iDrive Ultra powered stapling system.
more
By Emily Greenhalgh |
|
The University of Rhode Island is set to celebrate the opening of its newly completed $75 million building for the College of Pharmacy on Tuesday, Sept. 4 at 11 a.m.
more
By PBN Staff
|
|
East Providence biomedical company ProThera Biologics LLC - led by Rhode Island Hospital scientists Dr. Yow-Pin Lim, above, and Douglas Hixson - has received $750,000 in new funding from the National Institutes of Health and Slater Technology Fund.
more
By Patrick Anderson |